• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.

Leela Barham

Leela Barham is a freelance health economist and policy expert. She has published in peer-reviewed journals and presented at national and international conferences. She has provided advice to the Department of Health and Social Care on policy on pricing of branded medicines to inform the negotiation of a successor to the UK’s Pharmaceutical Price Regulation Scheme (PPRS), the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS), as well as worked with patient groups, the NHS, pharmaceutical companies and many others internationally on the economics of healthcare and pharmaceuticals. Contact Leela on leels@btinternet.com

Articles

Seeking Partnerships with Patients: ICER's Yvette Venable

Leela Barham talks to Yvette Venable, the Institute for Clinical Effectiveness Review's new Vice President of Patient Engagement, about how ICER is ramping up its efforts to bring patient organizations along on its journey.

Changing Top Trends in Health Economics and Operational Research

ISPOR has published its third issue of the top trends in HEOR. Leela Barham takes a look at how the list has changed over time.

Putting CADTH on the National and International Stage

Leela Barham talks to Dr. Brian O’Rourke, outgoing President and Chief Executive Officer of the Canadian Agency for Drugs and Technologies in Health (CADTH), about his 11 in years in the role.

ICER Names Drugs with Unsupported Price Increases

Leela Barham reacts to the Institute for Economic and Clinical Review's very first Unsupported Price Increase (UPI) report.